Blue background

Old Billingsgate in London, formerly the site of the world’s largest fish market, was the perhaps unlikely location for ‘Tech Day’, the city’s biggest event for start-ups. Your author, along with roughly 7,000 other visitors attended last Friday, meeting with around 200 start-ups. While the event was significantly smaller in scale than the comparable offering in New York which we visited last year (Los Angeles also hosts a similar tech day), it still provided a valuable opportunity to take the pulse of the industry.

In summary, while we were impressed by the vibrant nature of start-up culture in London, much of the ‘innovation’ on show seemed to be concentrated on already-popular areas. That We Work was one of the event’s main sponsors was perhaps a sign of the times. We struggled to get excited about entrepreneurs discussing ‘smart’ apps or ‘cloud native’ offerings, particularly those within the fintech or VR/AR space.

Nonetheless, boundaries continue to get pushed. Consider the following three examples. First, we met a company (Karakuri) claiming to be the world’s first fully customisable food preparation system combining robotics, automation and machine learning. The idea behind the business is to leverage technology to conceive of a world where meals can potentially be individually customised but mass produced; where freshly-made food could be as convenient as fast-food. Given the increased interest in healthy eating and food provenance as well as a growing prevalence of food allergies, this seems a logical area on which to focus. Also on the topic of food, the vision embodied by urbanagric is a potentially compelling one. We discussed earlier this year the case for agtech and bringing innovation to the farming industry by – in this instance – vertical indoor crop growth monitored remotely via intelligent sensors seems an area in which investment will only likely grow.

In a totally different area, CircaGene is a business that touches on two different important future trends: molecular diagnostics and cybersecurity. Understanding our DNA may impact what, for example, we choose to eat, but almost more crucial than deciphering our genes is making sure that the information we receive is stored securely and not compromised. The encryption of genetic data is therefore logical. Aggregating and anonymising it for broader insights represents a further opportunity. Expect more innovation in this area.     

Disclaimers

The document is provided for information purposes only and does not constitute investment advice or any recommendation to buy, or sell or otherwise transact in any investments. The document is not intended to be construed as investment research. The contents of this document are based upon sources of information which Heptagon Capital LLP believes to be reliable. However, except to the extent required by applicable law or regulations, no guarantee, warranty or representation (express or implied) is given as to the accuracy or completeness of this document or its contents and, Heptagon Capital LLP, its affiliate companies and its members, officers, employees, agents and advisors do not accept any liability or responsibility in respect of the information or any views expressed herein. Opinions expressed whether in general or in both on the performance of individual investments and in a wider economic context represent the views of the contributor at the time of preparation. Where this document provides forward-looking statements which are based on relevant reports, current opinions, expectations and projections, actual results could differ materially from those anticipated in such statements. All opinions and estimates included in the document are subject to change without notice and Heptagon Capital LLP is under no obligation to update or revise information contained in the document. Furthermore, Heptagon Capital LLP disclaims any liability for any loss, damage, costs or expenses (including direct, indirect, special and consequential) howsoever arising which any person may suffer or incur as a result of viewing or utilising any information included in this document. 

The document is protected by copyright. The use of any trademarks and logos displayed in the document without Heptagon Capital LLP’s prior written consent is strictly prohibited. Information in the document must not be published or redistributed without Heptagon Capital LLP’s prior written consent. 

Heptagon Capital LLP, 63 Brook Street, Mayfair, London W1K 4HS
tel +44 20 7070 1800
email [email protected] 

Partnership No: OC307355 Registered in England and Wales Authorised & Regulated by the Financial Conduct Authority 

Heptagon Capital Limited is licenced to conduct investment services by the Malta Financial Services Authority.

Related Insights

Season 6, Post 16: From golf course to warehouse
  • Future Trends Blog

Season 6, Post 16: From golf course to warehouse

Season 6, Post 15: AI and Its Discontents*
  • Future Trends Blog

Season 6, Post 15: AI and Its Discontents*

Season 6, Post 14: My type of fish
  • Future Trends Blog

Season 6, Post 14: My type of fish

GET THE UPDATES

Sign up to our monthly email newsletter for the latest fund updates, webcasts and insights.